FindTrial
Sign In

Tranexamic Acid (IV)

DRUG6 trials

Sponsors

Samsung Medical Center, Kaiser Permanente, Combined Military Hospital Multan, ScinnoHub Pharmaceutical Co., Ltd., The University of Hong Kong

Conditions

Benign Prostatic HyperplasiaBleedingBlood Loss During SurgeryBlood Loss, SurgicalCerebral PalsyCesarean SectionHip Surgery CorrectiveIntracerebral Hemorrhage

Phase 2

Study on BT-114143 Reducing Perioperative Bleeding in Total Knee Arthroplasty（TKA）
RecruitingNCT07127042
ScinnoHub Pharmaceutical Co., Ltd.Total Knee Arthroplasty
Start: 2025-08-27End: 2026-12-31Target: 270Updated: 2025-12-15

Phase 3

Use of Transexamic Acid in Hip Replacement
NCT02587845
Samsung Medical CenterBleeding, Transfusion Related Complication
Start: 2015-10-31End: 2016-12-31Target: 150Updated: 2015-10-27
Tranexamic Acid to Reduce Blood Loss After Varus Derotation Osteotomy
Not yet recruitingNCT07672158
Murdoch Childrens Research InstituteBlood Loss, Surgical, Cerebral Palsy, Hip Surgery Corrective +3
Start: 2026-07-01End: 2029-04-01Target: 52Updated: 2026-06-26

Phase 4

Effect of Tranexamic Acid on Intraoperative Blood Loss in Patients Undergoing Aquablation
Not yet recruitingNCT06710327
Kaiser PermanenteBenign Prostatic Hyperplasia
Start: 2025-01-31End: 2025-08-31Target: 56Updated: 2024-11-29
Tranexamic Acid to Reduce Blood Loss in Women Having Planned Cesarean Section
CompletedNCT07013812
Combined Military Hospital MultanBlood Loss During Surgery, Cesarean Section
Start: 2023-11-01End: 2024-04-30Updated: 2025-06-10

Unknown Phase

Precision Use of TXA in Intracerebral Hemorrhage
RecruitingNCT07365150
The University of Hong KongIntracerebral Hemorrhage
Start: 2026-01-01End: 2027-12-31Target: 70Updated: 2026-01-26